Hims & Hers Health ( (HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hims & Hers Health’s stock price took a hit after the FDA issued a warning letter criticizing their Super Bowl ad for weight loss claims, which failed to mention potential risks and violated drug promotion rules. The increased regulatory scrutiny, coupled with the company’s hefty marketing expenses, has raised concerns among analysts. This has led to a mixed outlook, as analysts express worries about slowing growth in core offerings and potential volatility from new product launches.
More about Hims & Hers Health
YTD Price Performance: 114.13%
Average Trading Volume: 35,668,762
Technical Sentiment Signal: Buy
Current Market Cap: $12.2B
For further insights into HIMS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.